Rights issue April 2023
The Board of Directors of Cereno Scientific resolved on April 20, 2023, to carry out a rights issue with preferential rights for existing shareholders.
Due to legal restriction, the information on this part of Cereno Scientific AB (publ)’s (“Cereno Scientific” or the “Company”) website is not accessible to certain persons. We kindly ask you to review the following information and provide the following confirmation each time you wish to access this part of the Company’s website. Please note that the terms set out below may be altered or updated and therefore it is important that you review them each time you visit this page.
NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, WHOLLY OR PARTLY, IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS), AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SWITZERLAND, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE PROHIBITED BY APPLICABLE LAW.
This website and the information contained herein is not intended for, and may not be accessed by, or distributed or disseminated to, persons resident or physically present in the United States of America (including its territories and possessions), Australia, Belarus, Canada, Hong Kong, Japan, New Zealand, Russia, Singapore, Switzerland, South Africa, South Korea, or any other jurisdiction where distribution would require additional prospectuses, registration measures, or other measures bedsides those required by Swedish law or otherwise would be in conflict with the rules of such jurisdiction or which cannot be made without application of exemptions in such jurisdiction. This website and the information contained herein do not constitute an offer to sell or the solicitation of an offer to purchase or acquire, any units, unit rights, paid subscribed units, or other securities in Cereno Scientific (“Securities”) to any person in said jurisdictions. The information on the websites may not be forwarded or reproduced in such a manner that contravenes such restrictions or would give cause to such requirements.
No Securities have been registered or will be registered under the United States Securities Act of 1933 as amened (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States of America and may not be offered, subscribed for, used, pledged, sold, resold, allotted, delivered, or otherwise transferred, directly or indirectly, in or into the United States of America except under an available exemption from, or in a transaction not subject to, the registration of requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States of America.
Within the European Economic Area (“EEA”), no public offering of Securities is made in other countries than Sweden. In other member states of the European Union (“EU”), such an offering of Securities may only be made in accordance with the Prospectus Regulation (EU) 2017/1129 (the “Prospectus Regulation”). In other member states of the EEA which have not implemented the Prospectus Regulation in its national legislation, any offer of Securities may only be made in accordance with an applicable exemption under national law.
All persons residing outside of the above mentioned jurisdictions who wish to access the documents contained on this website should first ensure that they are not subject to local laws or regulations that prohibit or restrict their right to access this website, or require registration or approval for any acquisition of securities by them. Cereno Scientific assumes no responsibility if there is a violation of applicable law and regulations by any person.
If you are not permitted to view materials on this website or are in any doubt as to whether you are permitted to view these materials, please exit this website.
Access to electronic versions of these materials is being made available on this website by the Company in good faith and for information purposes only.
By clicking “Confirm” you confirm and certify that:
(i) you have read and accepted the terms and restrictions set out above,
(ii) you are not a resident of or physically present in any of the above jurisdictions or any other restricted jurisdiction and are not a U.S. person (as defined in Regulation S under the Securities Act); and
(iii) you are either:
(a) a resident of or physically present in Sweden;
(b) if resident or physically present in a Member State of the European Economic Area other than Sweden, a qualified investor as defined in Regulation (EU) 2017/1129 of the European parliament and of the council; or
(c) otherwise authorized to access this information pursuant to applicable laws or regulations.